Recall company profile

Lloyd Inc. of Iowa Recalls

Overview of recall records associated with Lloyd Inc. of Iowa, including dates, categories and classifications where available.

20recall records
May 29, 2013latest record date
May 29, 2013earliest record date

Recall history in this database

Classification mix: Class II: 20.

DrugMay 29, 2013

Lloyd Thyro-Tab 0.050 mg recall — FDA D-433-2013

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIFDA: TerminatedLloyd Inc. of Iowa
DrugMay 29, 2013

Lloyd Thyro-Tab 0.150 mg recall — FDA D-442-2013

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIFDA: TerminatedLloyd Inc. of Iowa
DrugMay 29, 2013

Lloyd Thyro-Tab 0.075 mg recall — FDA D-435-2013

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIFDA: TerminatedLloyd Inc. of Iowa
DrugMay 29, 2013

Lloyd Thyro-Tab 0.112 mg recall — FDA D-439-2013

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIFDA: TerminatedLloyd Inc. of Iowa
DrugMay 29, 2013

Lloyd Thyro-Tab 0.088 mg recall — FDA D-437-2013

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIFDA: TerminatedLloyd Inc. of Iowa
DrugMay 29, 2013

Lloyd Thyro-Tab 0.125 mg recall — FDA D-440-2013

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIFDA: TerminatedLloyd Inc. of Iowa
DrugMay 29, 2013

Lloyd Thyro-Tab 0.100 mg recall — FDA D-438-2013

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIFDA: TerminatedLloyd Inc. of Iowa
DrugMay 29, 2013

Lloyd Thyro-Tab 0.137 mg recall — FDA D-441-2013

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIFDA: TerminatedLloyd Inc. of Iowa
DrugMay 29, 2013

Lloyd Thyro-Tab 0.175 mg recall — FDA D-443-2013

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIFDA: TerminatedLloyd Inc. of Iowa
DrugMay 29, 2013

Lloyd Thyro-Tab 0.200 mg recall — FDA D-444-2013

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Class IIFDA: TerminatedLloyd Inc. of Iowa

Understanding this recall history

This page summarizes recall records in which the official source identifies Lloyd Inc. of Iowa as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.

Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.